Crystal Structures of IL‐2‐inducible T cell Kinase Complexed with Inhibitors: Insights into Rational Drug Design and Activity Regulation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Chemical Biology and Drug Design

• Publication date

  2010-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1747-0285.2010.00993.xPMID 20545945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acoustic matrix microseeding: improving protein crystal growth with minimal chemical bias.

  2010cited by this paper
• 5-Aminomethylbenzimidazoles as potent ITK antagonists.

  2009cited by this paper
• The Tec kinases Itk and Rlk regulate conventional versus innate T‐cell development

  2009cited by this paper
• Structural biology contributions to tyrosine kinase drug discovery.

  2009cited by this paper
• Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.

  2009cited by this paper
• Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.

  2009cited by this paper
• SH2-dependent autophosphorylation within the Tec family kinase Itk.

  2009cited by this paper
• ITK inhibitors in inflammation and immune-mediated disorders.

  2009cited by this paper
• A quantitative analysis of kinase inhibitor selectivity

  2008cited by this paper
• The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.

  2008cited by this paper
• Selective targeting of ITK blocks multiple steps of HIV replication

  2008cited by this paper
• Classifying protein kinase structures guides use of ligand‐selectivity profiles to predict inactive conformations: Structure of lck/imatinib complex

  2007cited by this paper
• Cutting Edge: IL-1 Receptor-Associated Kinase 4 Structures Reveal Novel Features and Multiple Conformations

  2007cited by this paper
• The linker between SH2 and kinase domains positively regulates catalysis of the Tec family kinases.

  2007cited by this paper
• Molecular basis for sunitinib efficacy and future clinical development

  2007cited by this paper
• Mechanism and functional significance of Itk autophosphorylation.

  2007cited by this paper
• Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors.

  2007cited by this paper
• Methods of inhibiting Btk and syk protein kinase

  2007cited by this paper
• Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors.

  2006influential reference
• Protein Engineering of the Colony-stimulating Factor-1 Receptor Kinase Domain for Structural Studies*

  2006cited by this paper
• Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors.

  2006influential reference
• Corrigendum to ''Discovery and SAR of 2-amino-5-((thiomethyl)aryl)thiazoles as potent and selective Itk inhibitors'' (Bioorg. Med. Chem. Lett. 16 (2006) 2411-2415)

  2006cited by this paper
• A small molecule–kinase interaction map for clinical kinase inhibitors

  2005cited by this paper
• Crystal Structures of Interleukin-2 Tyrosine Kinase and Their Implications for the Design of Selective Inhibitors*

  2004influential reference
• Selective Itk inhibitors block T-cell activation and murine lung inflammation.

  2004cited by this paper
• The conformational plasticity of protein kinases.

  2002cited by this paper
• Protein crystallization by rational mutagenesis of surface residues: Lys to Ala mutations promote crystallization of RhoGDI.

  2001cited by this paper
• Crystallization and 1.1-A diffraction of chorismate lyase from Escherichia coli.

  2000cited by this paper
• Crystal structures of c-Src reveal features of its autoinhibitory mechanism.

  1999influential reference
• Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.

  1999cited by this paper
• Lck Phosphorylates the Activation Loop Tyrosine of the Itk Kinase Domain and Activates Itk Kinase Activity*

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• Peptide mechanics: A force field for peptides and proteins working with entire residues as smallest units

  1992cited by this paper
• Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Translation Functions Biological Crystallography Likelihood-enhanced Fast Translation Functions

  year unknowncited by this paper

• Interleukin-2-inducible T-cell kinase inhibition to block NF-κB signaling exerts anti-tumor effect and enhances chemotherapy in NK/T-cell lymphoma.

  2025cites this paper
• Small-molecule BTK inhibitors: From discovery to clinical application.

  2025cites this paper
• Conformational Selectivity of ITK Inhibitors: Insights from Molecular Dynamics Simulations

  2023cites this paper
• TWN-RENCOD: A novel method for protein binding site comparison

  2022cites this paper
• Reactivities of the Front Pocket N-Cap Cysteines in Human Kinases

  2021cites this paper
• Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases.

  2021cites this paper
• The Bruton’s tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody‐mediated T‐cell cytotoxicity

  2020cites this paper
• Affinity and Selectivity Assessment of Covalent Inhibitors by Free Energy Calculations

  2020cites this paper
• Structural basis of inhibitor selectivity in the BRD7/9 subfamily of bromodomains.

  2020cites this paper
• ProtCID: a data resource for structural information on protein interactions

  2019cites this paper
• ProtCID: A tool for hypothesis generation of the structures of protein interactions

  2019cites this paper
• Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation

  2019cites this paper
• Identification of inactive conformation‐selective interleukin‐2‐inducible T‐cell kinase (ITK) inhibitors based on second‐harmonic generation

  2018cites this paper
• Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances.

  2018cites this paper
• Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors.

  2016cites this paper
• Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib

  2015cites this paper
• Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study.

  2015cites this paper
• A structural atlas of kinases inhibited by clinically approved drugs.

  2014cites this paper
• Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors.

  2014cites this paper
• Sunitinib: from charge-density studies to interaction with proteins.

  2014influential citation
• Bruton's TK inhibitors: structural insights and evolution of clinical candidates.

  2014cites this paper
• Productive induced metastability in allosteric modulation of kinase function

  2014cites this paper
• Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.

  2014cites this paper
• Emergence of Polyclonal FLT3 Tyrosine Kinase Domain Mutations during Sequential Therapy with Sorafenib and Sunitinib in FLT3-ITD–Positive Acute Myeloid Leukemia

  2013cites this paper
• Emergence of polyclonal FLT 3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT 3-ITD-positive acute myeloid leukemia

  2013cites this paper
• Insight into the structural requirements of benzimidazole derivatives as interleukin-2 inducible t-cell kinase inhibitors by computational explorations

  2013cites this paper
• Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).

  2013cites this paper
• Advances in the design of ITK inhibitors

  2013cites this paper
• 3D-QSAR analysis of benzimidazole inhibitors of interleukin-2 inducible T cell kinase (ITK) considering receptor flexibility and water importance for molecular alignment

  2013cites this paper
• Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches

  2013cites this paper
• A new target for an old drug: identifying mitoxantrone as a nanomolar inhibitor of PIM1 kinase via kinome-wide selectivity modeling.

  2013cites this paper
• Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.

  2013cites this paper
• Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6

  2013cites this paper
• Cancer Therapy : Clinical Emergence of Polyclonal FLT 3 Tyrosine Kinase Domain Mutations during Sequential Therapy with Sorafenib and Sunitinib in FLT 3-ITD – Positive Acute Myeloid Leukemia

  2013cites this paper
• Nanolitre-scale crystallization using acoustic liquid-transfer technology

  2012influential citation
• A Novel Approach to the Discovery of Small‐Molecule Ligands of CDK2

  2012cites this paper
• Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies.

  2012cites this paper
• X-ray crystallographic structure-based design of selective thienopyrazole inhibitors for interleukin-2-inducible tyrosine kinase.

  2012cites this paper
• TEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma.

  2012cites this paper
• PROLIX: Rapid Mining of Protein-Ligand Interactions in Large Crystal Structure Databases

  2012cites this paper
• Conformation-specific effects of Raf kinase inhibitors.

  2012cites this paper
• Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures

  2011cites this paper
• X‐Ray Crystal Structure of Bone Marrow Kinase in the X Chromosome: A Tec Family Kinase

  2011cites this paper